CXCR5 and systemic lupus erythematosus: To assess the influence of immunosuppressive treatments on SLE patients’ ICP proliferative activity, proliferative activities for cMo, PC, CD8Tem, CXCR5− nB, and CXCR5− DNB were determined before and after treatment.